A barrier to progress: getting drugs to the brain


The specialist publication The Pharmaceutical Journal devotes a feature article to the efforts being made by researchers worldwide to get drugs across the blood-brain barrier in order to treat central nervous system disorders such as Alzheimer’s disease, depression, and epilepsy. Among the scientists mentioned is Ernest Giralt and the work performed by his lab in search for peptides to be used as Trojan horses to smuggle drugs across the barrier.

The Pharmaceutical Journal, Vol 298, No 7901, online | DOI: 10.1211/PJ.2017.20202723

Read more here: A barrier to progress: getting drugs to the brain ($)